RE:RE:RE:RE:RE:RE:FutureThere's a level of frustration with the share price as PGX is being proven out while the base business still exhibits10% annual growth yet the valuation is abysmal. Beyond improving the business and hoping that the market will recognize what Ceapro is doing, I can say that, it's not working.
When you see how other venture companies with less can command a higher valuation, it goes to marketing (promoting) of the company. Canadian microcap retail investors should be the focus of targeted IR campaigns. The Small Cap Discoveries was a great first move in the right direction, one can see the volume preceding the posting of the interview on YT (Paul from SCD allows his viewers a heads up).